What is the interpretation of fasting insulin levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Fasting insulin levels should be interpreted in the context of overall health status and symptoms, with normal levels typically ranging from 2-25 μIU/mL (14-174 pmol/L), and optimal levels below 10 μIU/mL, as elevated levels may indicate insulin resistance and increased risk for metabolic disorders 1. To interpret fasting insulin results properly, it is essential to fast for 8-12 hours before testing and consider the result alongside other metrics like fasting glucose and HbA1c. Some key points to consider when interpreting fasting insulin levels include:

  • Elevated insulin levels may indicate prediabetes, metabolic syndrome, or polycystic ovary syndrome, while very low levels could suggest pancreatic insufficiency or type 1 diabetes.
  • The homeostatic model assessment of insulin resistance (HOMA-IR) calculation, which combines fasting insulin and glucose values, provides a more comprehensive assessment of insulin resistance.
  • Lifestyle modifications, including weight loss, regular exercise, and reducing refined carbohydrates, can improve insulin sensitivity if levels are elevated, as supported by studies such as 1 and 1.
  • It is crucial to discuss results with a healthcare provider who can interpret them in the context of overall health status and symptoms, taking into account the latest guidelines and recommendations, such as those outlined in 1 and 1.
  • Recent studies, such as 1, emphasize the importance of considering individual factors, including age, weight, and overall health, when interpreting fasting insulin levels and developing treatment plans.
  • Additionally, studies like 1 highlight the significance of waist circumference and visceral fat in assessing metabolic risk and insulin resistance, particularly in children and adolescents.

From the Research

Interpreting Fasting Insulin Levels

Fasting insulin levels can be used to assess insulin sensitivity and identify prediabetes. The following points summarize how to interpret fasting insulin levels:

  • Fasting insulin levels can be used to calculate the Quantitative Insulin Sensitivity Check Index (QUICKI), which is a measure of insulin sensitivity 2
  • A higher fasting insulin level is associated with a higher likelihood of prediabetes, with a level above 9.0 microIU/mL correctly identifying prediabetes in 80% of affected patients 3
  • Fasting insulin levels can be used in combination with other clinical and laboratory attributes, such as the homeostasis model assessment of insulin resistance (HOMA-IR), to predict the presence of prediabetes 3

Factors Affecting Fasting Insulin Levels

Several factors can affect fasting insulin levels, including:

  • Insulin resistance, which can be improved with medications such as metformin and pioglitazone 2, 4
  • Obesity, which is a common comorbidity in patients with prediabetes and type 2 diabetes 3, 5
  • Age, with older age being associated with a higher likelihood of prediabetes 3
  • Diastolic blood pressure, with higher blood pressure being associated with a higher likelihood of prediabetes 3

Clinical Applications of Fasting Insulin Levels

Fasting insulin levels have several clinical applications, including:

  • Identifying patients with prediabetes, who may benefit from lifestyle interventions or pharmacological therapy to prevent progression to type 2 diabetes 3
  • Monitoring the effectiveness of treatments for insulin resistance, such as metformin and pioglitazone 2, 4
  • Assessing the risk of cardiovascular disease, which is increased in patients with insulin resistance and type 2 diabetes 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Long-term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus.

Diabetic medicine : a journal of the British Diabetic Association, 2005

Research

Identifying prediabetes using fasting insulin levels.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2010

Research

Metformin and pioglitazone: Effectively treating insulin resistance.

Current medical research and opinion, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.